P-103: Considerations for statistical analysis when QALYs are a co-primary endpoint in a large phase II/III randomised controlled trial

Royle, K-L, Martin, A orcid.org/0000-0002-2559-6483, Meads, D et al. (2 more authors) (2019) P-103: Considerations for statistical analysis when QALYs are a co-primary endpoint in a large phase II/III randomised controlled trial. In: 5th International Clinical Trials Methodology Conference (ICTMC 2019), 06-09 Oct 2019, Brighton, UK.

Metadata

Authors/Creators:
Dates:
  • Published: October 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Sep 2020 10:22
Last Modified: 24 Sep 2020 10:22
Status: Published
Identification Number: https://doi.org/10.1186/s13063-019-3688-6
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics